Reported 2 days ago
Pfizer (PFE) is positioned to potentially continue its trend of beating earnings estimates in its next earnings report, scheduled for November 4, 2025. The pharmaceutical company has historically surpassed estimates, achieving an average beat of 39.12% over the last two quarters. With a positive Earnings ESP of +2.53% and a Zacks Rank of #3, analysts are optimistic about Pfizer's near-term earnings potential, suggesting that another earnings beat may be on the horizon.
Source: YAHOO